1-deoxynojirimycin has been researched along with Albuminuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishimura, I; Kannno, S; Node, K; Yokoyama, H | 1 |
| Coniff, RF; Davidson, JA; Feig, PU; Haffner, SM; Johnston, PS; Krol, A | 1 |
2 trial(s) available for 1-deoxynojirimycin and Albuminuria
| Article | Year |
|---|---|
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adiponectin; Albuminuria; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Imino Pyranoses; Male; Middle Aged | 2007 |
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.
Topics: 1-Deoxynojirimycin; Albuminuria; Blood Glucose; Creatinine; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Enzyme Inhibitors; Female; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Hispanic or Latino; Humans; Imino Pyranoses; Insulin; Lipids; Male; Middle Aged; Placebos; Postprandial Period; Time Factors; Treatment Outcome | 1998 |